Peter A. Ljubenkov

1.7k total citations
19 papers, 222 citations indexed

About

Peter A. Ljubenkov is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Peter A. Ljubenkov has authored 19 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Peter A. Ljubenkov's work include Alzheimer's disease research and treatments (10 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Peter A. Ljubenkov is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Peter A. Ljubenkov collaborates with scholars based in United States, Netherlands and Ireland. Peter A. Ljubenkov's co-authors include Adam L. Boxer, Lawren VandeVrede, Bruce L. Miller, Julio C. Rojas, Michael D. Geschwind, Gil D. Rabinovici, Mary Koestler, Renaud La Joie, Ariane E. Welch and Amelia Strom and has published in prestigious journals such as Nature Medicine, Neurology and JAMA Neurology.

In The Last Decade

Peter A. Ljubenkov

18 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Ljubenkov United States 8 135 91 54 45 45 19 222
Emily J. Hill United States 7 128 0.9× 61 0.7× 41 0.8× 67 1.5× 42 0.9× 19 243
Léon Beyer Germany 9 164 1.2× 68 0.7× 112 2.1× 74 1.6× 59 1.3× 17 320
Jessica E. Walker United States 6 75 0.6× 125 1.4× 35 0.6× 33 0.7× 34 0.8× 15 224
Tien Dam United States 6 98 0.7× 133 1.5× 21 0.4× 32 0.7× 44 1.0× 14 231
João Durães Portugal 8 90 0.7× 47 0.5× 69 1.3× 51 1.1× 45 1.0× 30 190
Alfredo Megaro Italy 8 78 0.6× 80 0.9× 38 0.7× 86 1.9× 34 0.8× 12 258
Natalia Ermann Germany 5 187 1.4× 78 0.9× 134 2.5× 79 1.8× 57 1.3× 6 299
Erin Franklin United States 7 173 1.3× 54 0.6× 112 2.1× 56 1.2× 34 0.8× 13 238
Harli Grant United States 7 146 1.1× 92 1.0× 118 2.2× 58 1.3× 46 1.0× 12 307

Countries citing papers authored by Peter A. Ljubenkov

Since Specialization
Citations

This map shows the geographic impact of Peter A. Ljubenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Ljubenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Ljubenkov more than expected).

Fields of papers citing papers by Peter A. Ljubenkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Ljubenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Ljubenkov. The network helps show where Peter A. Ljubenkov may publish in the future.

Co-authorship network of co-authors of Peter A. Ljubenkov

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Ljubenkov. A scholar is included among the top collaborators of Peter A. Ljubenkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Ljubenkov. Peter A. Ljubenkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Villanueva-Meyer, Javier, Winston Chiong, Courtney Lane‐Donovan, et al.. (2025). Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease. Neurology Clinical Practice. 15(4). e200508–e200508.
2.
Ljubenkov, Peter A., Shubham Singh, Sebastian Boland, et al.. (2025). Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype‐specific, and severity‐linked alterations. Alzheimer s & Dementia. 21(9). e70631–e70631. 1 indexed citations
3.
VandeVrede, Lawren, Peter A. Ljubenkov, Adam M. Staffaroni, et al.. (2025). Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 17(1). e70078–e70078. 1 indexed citations
4.
Roy, Ashlin R. K., Peter A. Ljubenkov, Hilary W. Heuer, et al.. (2024). Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy. NeuroImage Clinical. 43. 103649–103649. 1 indexed citations
5.
Samudra, Niyatee, D. Luke Fischer, Argentina Lario Lago, et al.. (2024). Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimer s & Dementia. 20(5). 3334–3341. 22 indexed citations
6.
Cho, Hanna, Mark Sanderson‐Cimino, Lea T. Grinberg, et al.. (2024). Diagnostic Performance of Plasma P‐tau217, NfL, and GFAP for Predicting Alzheimer’s Disease Neuropathology Across Diverse Neurodegenerative Syndromes. Alzheimer s & Dementia. 20(S2). 1 indexed citations
7.
Ljubenkov, Peter A. & Gil D. Rabinovici. (2023). Silencing tau to treat early Alzheimer’s disease. Nature Medicine. 29(6). 1320–1321. 4 indexed citations
8.
Ramos, Eliana Marisa, Zhongan Yang, Luke W. Bonham, et al.. (2022). Case Report: Novel CSF1R Variant in a Patient With Behavioral Variant Frontotemporal Dementia Syndrome With Prodromal Repetitive Scratching Behavior. Frontiers in Neurology. 13. 909944–909944. 3 indexed citations
9.
Ljubenkov, Peter A., Adam M. Staffaroni, Julio C. Rojas, et al.. (2022). Introduction to Veri‐T: A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial of Verdiperstat in Patients with svPPA Due to FTLD‐TDP. Alzheimer s & Dementia. 18(S10). 1 indexed citations
10.
11.
VandeVrede, Lawren, Peter A. Ljubenkov, Julio C. Rojas, Ariane E. Welch, & Adam L. Boxer. (2020). Four-Repeat Tauopathies: Current Management and Future Treatments. Neurotherapeutics. 17(4). 1563–1581. 29 indexed citations
12.
VandeVrede, Lawren, Julio C. Rojas, Ping Wang, et al.. (2020). Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD. Alzheimer s & Dementia. 16(S5). 3 indexed citations
13.
VandeVrede, Lawren, Daniel M. Gibbs, Mary Koestler, et al.. (2020). Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12101–e12101. 52 indexed citations
14.
VandeVrede, Lawren, Marian L. Dale, Scott Fields, et al.. (2020). Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy. Movement Disorders Clinical Practice. 7(4). 440–447. 43 indexed citations
15.
Ljubenkov, Peter A., Zachary Miller, Paige Mumford, et al.. (2019). Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency. Frontiers in Neurology. 10. 1004–1004. 8 indexed citations
16.
Boeve, Bradley F., Howard J. Rosen, Adam L. Boxer, et al.. (2019). The Multidomain Impairment Rating (MIR) Scale: Initial Reliability Data on a Multidimensional Scale for FTLD (P5.1-010). Neurology. 92(15_supplement). 1 indexed citations
17.
Liu, Andy, Adam M. Staffaroni, Nicholas Olney, et al.. (2019). Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia. JAMA Neurology. 77(3). 358–358. 15 indexed citations
18.
Ljubenkov, Peter A. & Bruce L. Miller. (2016). A Clinical Guide to Frontotemporal Dementias. FOCUS The Journal of Lifelong Learning in Psychiatry. 14(4). 448–464. 18 indexed citations
19.
Geschwind, Michael D. & Peter A. Ljubenkov. (2016). Dementia. Seminars in Neurology. 36(4). 397–404. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily J. Hill Breakdown of academic impact, for papers by Léon Beyer Breakdown of academic impact, for papers by Jessica E. Walker Breakdown of academic impact, for papers by Tien Dam Breakdown of academic impact, for papers by João Durães Breakdown of academic impact, for papers by Alfredo Megaro Breakdown of academic impact, for papers by Natalia Ermann Breakdown of academic impact, for papers by Erin Franklin Breakdown of academic impact, for papers by Harli Grant
Rankless by CCL
2026